180 likes | 262 Views
The LEDGF-integrase interaction as a new target for ART. Linos Vandekerckhove , Jan De Rijck, Rik Gijsbers, Myriam Witvrouw, Frauke Christ and Zeger Debyser Molecular Medicine, K.U.Leuven, Belgium. HIV-1 replication cycle and role of IN. entry attachment fusion. reverse transcription.
E N D
The LEDGF-integrase interaction as a new target for ART Linos Vandekerckhove, Jan De Rijck, Rik Gijsbers,Myriam Witvrouw,Frauke Christ and Zeger Debyser Molecular Medicine, K.U.Leuven, Belgium
HIV-1 replication cycle and role of IN entry attachment fusion reverse transcription nuclear import integration transcription translation budding maturation
LEDGF/p75, a novel co-factor of HIV integration • Identified as binding partner of HIV-1 IN (Cherepanov et al., 2003; Maertens et al., 2003) • LEDGF/p75 is lentiviral specific and increases the affinity of IN for DNA (Busschots et al., 2005)
The cellular function LEDGF/p75 • Splice variant p52 • Hepatoma derived growth factors (Conserved PWWP domain) • LEDGF/p75 increases the resistance against environmental stress (Upregulates stress reponse genes)
Importance of LEDGF/p75 in HIV replication • The IN Q168A interaction mutant is defective for replication (Emiliani et al., 2005). • Knock-down using RNAi inhibits HIV replication significantly (Vandekerckhove et al., 2006). • Overexpression of C-terminal fragments
The dominant binding partner of HIV-1 integrase (IN) in human cells Potential targeting factor of lentiviral DNA to the chromosomes Potential role of LEDGF during HIV replication Human DNA histones LEDGF LEDGF LEDGF LEDGF IN ViralDNA
C-terminal fragments of LEDGF/p75 p52 LEDGF/p75 p75 1 91 148 156 325 429 530 aa 347 IBD PWWP AT NLS integrase binding domain DNA binding domain D366A (Cherepanov et al., 2004) 325 530 aa D 325 IBD eGFP Puro IRES IBD 429 aa 347 IBD Puro eGFP IRES
In vitro pull-down MBP-D325 D366A MBP-D325 D366A LEDGF/p75 LEDGF/p75 MBP- D325 MBP- D325 MBP-IBD MBP-IBD - LEDGF/p75 70 kDa - - MBP-D325 55 kDa - - MBP-IBD 45 kDa - - His6-IN
HeLaP4 cell lines stably overexpressing C-terminal LEDGF fragments HeLaP4 eGFP-D325 D366A HeLaP4 eGFP-IBD HeLaP4 eGFP-D325 HeLaP4 eGFP HeLaP4
Cytopathogenic effect of HIV-1on HeLaP4 cells HeLaP4 HeLaP4eGFP HeLaP4eGFP-Δ325D366A HeLaP4eGFP-Δ325 HeLaP4eGFP-IBD
HIV replication is strongly inhibited by over expression of C-terminal LEDGF fragments (Vandekerckhove, De Rijck et al., submitted for publication)
MT4- breakthrough experiment strain (MOI:1) HIV-1 NL4.3 HIV-1 IIIb
Q-PCR to pinpointthe replication block Reverse transcription Non-Integrated Nuclear Viral DNA Integrated proviral DNA
MT4-breakthrough experimentDKA resistant strain (MOI:1) HIV-1 L-708,906
Conclusions • LEDGF/p75 has a key-role in HIV replication • IBD competes with LEDGF/p75 for IN binding • potent inhibition of HIV replication at the integration step • proof-of-concept for LEDGF-based anti-HIV therapy
Acknowledgements Molecular Medicine – K.U.Leuven, Belgium Jan De Rijck, Rik Gijsbers, Frauke Christ, Katrien Busschots, Koen Bartholomeeusen, Barbara Podessu, Martine Michiels, Myriam Witvrouw, Zeger Debyser Laboratory for Biomolecular Dynamics – K.U.Leuven, Belgium Jo Vercammen, Jelle Hendrickx, Yves Engelborghs Institut Cochin - Paris, France Stephane Emiliani, Nicole Kubat,Richard Benarous